Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies

Neuroendocrine neoplasia (NEN) comprises heterogeneous tumors that are challenging to diagnose and, especially in cases of poorly differentiated (G3) NEN, are associated with very limited survival. Novel biomarkers allowing an early diagnosis as well as an optimal selection of suitable treatment opt...

Full description

Bibliographic Details
Main Authors: Burcin Özdirik, Anna Stueven, Jana Knorr, Lukas Geisler, Raphael Mohr, Münevver Demir, Teresa Hellberg, Sven H. Loosen, Fabian Benz, Bertram Wiedenmann, Frank Tacke, Alexander Wree, Henning Jann, Christoph Roderburg
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Journal of Clinical Medicine
Subjects:
soluble urokinase-type plasminogen activator receptor
neuroendocrine tumor
neuroendocrine carcinoma
biomarker
survival
Online Access:https://www.mdpi.com/2077-0383/9/6/1647

Internet

https://www.mdpi.com/2077-0383/9/6/1647

Similar Items